Cure TV

Dr. Thomas Marron explains how therapeutic vaccines differ from preventative vaccines in lung cancer care.

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells.

Dr. Ajay Gupta of the Roswell Park Comprehensive Cancer Center discussed basics of gastrointestinal stromal tumors.

Dr. Daniel Peters discussed targeted therapies and regimens that patients with acute myeloid leukemia, or AML, should be aware of.

Dr. Girindra Raval sat down for an interview with CURE to discuss what patients with EGFR-mutated lung cancer should know about their treatment options.

Nona Baker, who was first diagnosed with a blood cancer in 1991, shares her experience with polycythemia vera.

Dr. Charles M. Rudin discussed recent treatment advancements for patients with small cell lung cancer.

Cindy and Katie share how finding a friend who understood the caregiving journey made the experience less isolating and helped them navigate loss and hope.

An expert explained what patients newly diagnosed with gastrointestinal stromal tumors need to know.

Dr. Daniel J. Boffa discusses advancements in lung cancer care, including the role of minimally invasive surgical techniques and new systemic therapies.

Dr. Lanyi Nora Chen, sat down for a live interview with CURE, in which, she shares her advice for newly diagnosed patients with lung cancer.

CURE spoke with Dr. Marina Kremyanskaya about the treatment landscape for patients with polycythemia vera.

After more than 30 years since she was first diagnosed with a myeloproliferative neoplasm, Nona Baker is hopeful for the future thanks to current clinical trial landscape.

Dr. Pamela L. Kunz sat down for an interview with CURE to discuss resources and ongoing initiatives that may help patients with this disease.

Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered unattainable.

Nona Baker received a diagnosis of essential thrombocythemia in 1991, followed by polycythemia vera in 2004.

Young adults with newly diagnosed cancer may feel overwhelmed, but open communication with doctors and support groups can help them feel less alone.

Dr. Joshua Sabai spoke with Dr. Chandler Park about the latest advances in kidney cancer, highlighting clinical trials that are shaping care for patients.

In honor of Lung Cancer Awareness Month, CURE spoke with Dr. Daniel J. Boffa about how the understanding of lung cancer is evolving beyond smoking.

Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care.

Dr. Joshua Sabari sat down with Dr. Michael Cecchini to discuss advances in colorectal cancer management and key data presented at the 2025 ESMO Congress.

After her own breast cancer treatment, Maureen advocated for legislation to make scalp cooling more accessible for patients seeking to preserve their hair.

Ten years after first being diagnosed with breast cancer, Cynthia Malaran said she still faces some side effects from treatment, but she has found strategies for coping.

Tracy Milgram-Posner sat down for an interview with CURE to discuss BRCAStrong and the impact she hopes to make for anyone with breast cancer.

Dr. Joshua Sabari, Dr. Petros Grivas, and Dr. Chandler Park discuss new developments in perioperative therapy for muscle-invasive bladder cancer.

Four-time non-Hodgkin lymphoma survivor Shell Rowe knows very well about the importance of finding the lighthearted side of an otherwise serious situation.

Experts highlight perioperative Padcev plus Keytruda in bladder cancer, showing potential practice-changing results from ESMO 2025 for patients.